Electra Therapeutics, Inc. (ETRA) stock
ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$8.35+0.04 (+0.48%)
Close on Nov 17, 2026Market cap $524.94MP/E –Yield –
Electra Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
No operating cash flow figures for Electra Therapeutics
Electra Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?